Skip to main content

Want a detailed portfolio tracker?

Jade Biosciences (JBIO) P/E (2021 - 2026)

Jade Biosciences (JBIO) P/E from Sep 30, 2021 to Jul 21, 2026. The TTM Jade Biosciences (JBIO) P/E is -6.37. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Jade Biosciences (JBIO)

YearP/EChange
2026-6.37+53.65%
2025-4.15-89.06%
2024-37.89-87.23%
2023-296.69-47.08%
2022-560.61-19.86%
2021-699.51N/A

Comparison Jade Biosciences (JBIO) P/E with competitors

Jade Biosciences (JBIO) P/E is -6.37.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.07%
ENLVEnlivex Ltd0.07-101.17%
FGENFibroGen Inc0.24-103.77%
CHRSCoherus Biosciences Inc0.85-113.32%
FBIOFortress Biotech Inc0.95-114.89%
ORMPOramed Pharmaceuticals Inc1.50-123.59%
AGENAgenus Inc3.01-147.23%
INVAInnoviva Inc3.15-149.49%
VXRTVaxart Inc3.55-155.70%
CRMDCorMedix Inc3.63-156.94%
CVACCureVac N.V.4.45-169.76%
GLPGGalapagos NV4.86-176.25%
SRPTSarepta Therapeutics Inc4.88-176.61%
ABEOAbeona Therapeutics Inc5.39-184.54%
ABUSArbutus Biopharma Corp5.60-187.81%
ZVRAZevra Therapeutics Inc5.89-192.38%
SPROSpero Therapeutics Inc6.23-197.74%
CGENCompugen Ltd6.31-199.08%
RIGLRigel Pharmaceuticals6.87-207.84%
SLXNSilexion Therapeutics Corp7.30-214.49%
OMEROmeros Corporation9.26-245.29%
AUPHAurinia Pharmaceuticals Inc9.58-250.41%
PLXProtalix BioTherapeutics Inc10.89-270.91%
ACADAcadia Pharmaceuticals Inc11.73-284.05%
TBPHTheravance Biopharma Inc12.26-292.42%
ADMAAdma Biologics Inc12.42-294.87%
HRMYHarmony Biosciences Holdings Inc13.82-316.87%
SABSSAB Biotherapeutics Inc14.14-321.83%
NAGENiagen Bioscience Inc14.82-332.53%
INCYIncyte Corp15.82-348.30%
REGNRegeneron Pharmaceuticals Inc15.86-348.83%
PBYIPuma Biotechnology Inc17.32-371.73%
CPRXCatalyst Pharmaceuticals Inc17.44-373.67%
EXELExelixis Inc17.54-375.22%
TGTXTG Therapeutics Inc18.97-397.62%
MDXGMimedx Group Inc20.55-422.52%
XOMAXOMA Royalty Corp22.87-458.97%
ARGXArgen X SE24.30-481.31%
CTMXCytomX Therapeutics Inc24.82-489.52%
XOMAOXOMA Royalty Corp25.34-497.73%
HALOHalozyme Therapeutics Inc25.62-502.11%
XOMAPXOMA Royalty Corp25.67-502.84%
VRTXVertex Pharmaceuticals Inc27.99-539.32%
RPRXRoyalty Pharma plc - Class A28.69-550.19%
SLNOSoleno Therapeutics Inc29.02-555.34%
ASNDAscendis Pharma A/S30.09-572.13%
LGNDLigand Pharmaceuticals Inc - Class B37.91-694.95%
APLSApellis Pharmaceuticals Inc39.02-712.36%
BMRNBiomarin Pharmaceutical Inc42.21-762.43%
KRYSKrystal Biotech Inc45.34-811.57%
ONCBeiGene Ltd69.54-1191.29%
PHARPharming Group N.V.75.03-1277.37%
TECHBio-Techne Corp101.96-1700.03%
VCELVericel Corp109.92-1824.99%
ALNYAlnylam Pharmaceuticals Inc117.96-1951.22%
GMABGenmab140.29-2301.57%
TLXTelix Pharmaceuticals Ltd162.15-2644.65%
CORTCorcept Therapeutics Inc212.86-3440.36%